Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer - Related Studies

Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer

This study is ongoing, but not recruiting participants.

Study NCT00066300. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia
		Lymphoma
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Myelodysplastic-Myeloproliferative Diseases
		Myeloproliferative Disorders
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Hematologic Diseases
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		cyclophosphamide
		cyclosporine
		fludarabine phosphate
		therapeutic allogeneic lymphocytes
		radiation therapy

5	Additional drug interventions recognized in this trial
		Cyclosporins
		Fludarabine
		Fludarabine monophosphate

6	More general drug interventions related to this trial
		Alkylating Agents
		Anti-Infective Agents
		Antifungal Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		National Heart, Lung, and Blood Institute (NHLBI)